speb/financial-data huggingface dataset:
TAK income_statement (annual, 2025-03-31) — Total Other Finance Cost: 42881000000.00
TAK balance_sheet (annual, 2025-03-31) — Total Tax Payable: 133497000000.00
TAK balance_sheet (quarterly, 2025-03-31) — Total Tax Payable: 133497000000.00
TAK income_statement (annual, 2025-03-31) — Total Unusual Items: -126744000000.00
TAK income_statement (annual, 2025-03-31) — Total Unusual Items Excluding Goodwill: -126744000000.00
TAK balance_sheet (annual, 2025-03-31) — Tradeand Other Payables Non Current: 317000000.00
TAK balance_sheet (quarterly, 2025-03-31) — Tradeand Other Payables Non Current: 317000000.00
TAK balance_sheet (annual, 2025-03-31) — Treasury Shares Number: 17299963.00
TAK balance_sheet (quarterly, 2025-03-31) — Treasury Shares Number: 17299963.00
TAK balance_sheet (annual, 2025-03-31) — Treasury Stock: 74815000000.00
TAK balance_sheet (quarterly, 2025-03-31) — Treasury Stock: 74815000000.00
TAK cash_flow (annual, 2025-03-31) — Unrealized Gain Loss On Investment Securities: -602000000.00
TAK cash_flow (quarterly, 2025-03-31) — Unrealized Gain Loss On Investment Securities: -2855000000.00
TAK balance_sheet (annual, 2025-03-31) — Work In Process: 552200000000.00
TAK balance_sheet (quarterly, 2025-03-31) — Work In Process: 552200000000.00
TAK balance_sheet (annual, 2025-03-31) — Working Capital: 14671000000.00
TAK balance_sheet (quarterly, 2025-03-31) — Working Capital: 14671000000.00
TAK income_statement (annual, 2025-03-31) — Write Off: 6812000000.00
TAK income_statement (quarterly, 2025-06-30) — +Operating Expense: 537445000000.00
TAK income_statement (quarterly, 2025-06-30) — +Total Revenue: 1106685000000.00
TAK balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 421308000000.00
TAK balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 665632000000.00
TAK balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 1790509000000.00
TAK income_statement (quarterly, 2025-06-30) — Amortization: 131638000000.00
TAK income_statement (quarterly, 2025-06-30) — Amortization Of Intangibles Income Statement: 131638000000.00
TAK cash_flow (quarterly, 2025-06-30) — Asset Impairment Charge: 2357000000.00
TAK balance_sheet (quarterly, 2025-06-30) — Assets Held For Sale Current: 0.00
TAK balance_sheet (quarterly, 2025-06-30) — Available For Sale Securities: 337173000000.00
TAK income_statement (quarterly, 2025-06-30) — Basic Average Shares: 3129459316.00
TAK income_statement (quarterly, 2025-06-30) — Basic EPS: 39.70
TAK cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 385113000000.00
TAK cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -75068000000.00
TAK balance_sheet (quarterly, 2025-06-30) — Capital Stock: 1694711000000.00
TAK balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 350008000000.00
TAK balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 419175000000.00
TAK cash_flow (quarterly, 2025-06-30) — Cash Dividends Paid: -145295000000.00
TAK cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: -214900000000.00
TAK cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -33193000000.00
TAK cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: 215422000000.00
TAK cash_flow (quarterly, 2025-06-30) — Change In Inventory: -13069000000.00
TAK cash_flow (quarterly, 2025-06-30) — Change In Other Current Liabilities: -17531000000.00
TAK cash_flow (quarterly, 2025-06-30) — Change In Other Working Capital: -23404000000.00
TAK cash_flow (quarterly, 2025-06-30) — Change In Payable: -27780000000.00
TAK cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: -27780000000.00
TAK cash_flow (quarterly, 2025-06-30) — Change In Receivables: 48083000000.00
TAK cash_flow (quarterly, 2025-06-30) — Change In Working Capital: -33701000000.00
TAK cash_flow (quarterly, 2025-06-30) — Changes In Cash: -32670000000.00
TAK balance_sheet (quarterly, 2025-06-30) — Common Stock: 1694711000000.00
TAK balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 6865259000000.00
TAK cash_flow (quarterly, 2025-06-30) — Common Stock Payments: -51603000000.00
TAK income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 384675000000.00
TAK balance_sheet (quarterly, 2025-06-30) — Current Assets: 2513122000000.00
TAK balance_sheet (quarterly, 2025-06-30) — Current Debt: 371143000000.00
TAK balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 371143000000.00
TAK balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 2169586000000.00
TAK balance_sheet (quarterly, 2025-06-30) — Current Provisions: 504069000000.00
TAK cash_flow (quarterly, 2025-06-30) — Deferred Income Tax: 26351000000.00
TAK cash_flow (quarterly, 2025-06-30) — Deferred Tax: 26351000000.00
TAK cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 181636000000.00
TAK income_statement (quarterly, 2025-06-30) — Depreciation Amortization Depletion Income Statement: 131638000000.00
TAK cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 181636000000.00
TAK income_statement (quarterly, 2025-06-30) — Depreciation And Amortization In Income Statement: 131638000000.00
TAK income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 3176351783.00
TAK income_statement (quarterly, 2025-06-30) — Diluted EPS: 39.12
TAK income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 124243000000.00
TAK cash_flow (quarterly, 2025-06-30) — Dividends Received Cfi: 250000000.00
TAK income_statement (quarterly, 2025-06-30) — EBIT: 257788000000.00
TAK income_statement (quarterly, 2025-06-30) — EBITDA: 439424000000.00
TAK income_statement (quarterly, 2025-06-30) — Earnings From Equity Interest: -536000000.00
TAK cash_flow (quarterly, 2025-06-30) — Earnings Losses From Equity Investments: 536000000.00
TAK cash_flow (quarterly, 2025-06-30) — Effect Of Exchange Rate Changes: -2435000000.00
TAK balance_sheet (quarterly, 2025-06-30) — Employee Benefits: 141512000000.00
TAK cash_flow (quarterly, 2025-06-30) — End Cash Position: 350008000000.00
TAK cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: -214900000000.00
TAK cash_flow (quarterly, 2025-06-30) — Free Cash Flow: 140355000000.00
TAK cash_flow (quarterly, 2025-06-30) — Gain Loss On Sale Of Business: -17900000000.00
TAK cash_flow (quarterly, 2025-06-30) — Gain Loss On Sale Of PPE: 584000000.00
TAK balance_sheet (quarterly, 2025-06-30) — Goodwill: 5295871000000.00
TAK balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 8718413000000.00
TAK income_statement (quarterly, 2025-06-30) — Gross Profit: 722010000000.00
TAK balance_sheet (quarterly, 2025-06-30) — Income Tax Payable: 150965000000.00
TAK income_statement (quarterly, 2025-06-30) — Interest Expense: 107158000000.00
TAK income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 107158000000.00
TAK income_statement (quarterly, 2025-06-30) — Interest Income: 73758000000.00
TAK income_statement (quarterly, 2025-06-30) — Interest Income Non Operating: 73758000000.00
TAK cash_flow (quarterly, 2025-06-30) — Interest Paid Cff: -16692000000.00
TAK cash_flow (quarterly, 2025-06-30) — Interest Received Cfi: 4850000000.00
TAK balance_sheet (quarterly, 2025-06-30) — Inventory: 1240676000000.00
TAK balance_sheet (quarterly, 2025-06-30) — Invested Capital: 11371201000000.00
TAK cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -33193000000.00
TAK balance_sheet (quarterly, 2025-06-30) — Investmentin Financial Assets: 337173000000.00
TAK balance_sheet (quarterly, 2025-06-30) — Investments And Advances: 347120000000.00
TAK cash_flow (quarterly, 2025-06-30) — Issuance Of Debt: 183555000000.00
TAK balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 4134799000000.00
TAK balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 4134799000000.00
TAK cash_flow (quarterly, 2025-06-30) — Long Term Debt Issuance: 183555000000.00
TAK cash_flow (quarterly, 2025-06-30) — Long Term Debt Payments: -137501000000.00
TAK balance_sheet (quarterly, 2025-06-30) — Long Term Equity Investment: 9947000000.00
TAK balance_sheet (quarterly, 2025-06-30) — Long Term Provisions: 34265000000.00
TAK balance_sheet (quarterly, 2025-06-30) — Minority Interest: 921000000.00
TAK income_statement (quarterly, 2025-06-30) — Minority Interests: -36000000.00
TAK cash_flow (quarterly, 2025-06-30) — Net Business Purchase And Sale: 29291000000.00
TAK cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: -51603000000.00
TAK balance_sheet (quarterly, 2025-06-30) — Net Debt: 4155934000000.00
TAK income_statement (quarterly, 2025-06-30) — Net Income: 124243000000.00
TAK income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 124243000000.00
TAK income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 124279000000.00
TAK income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 124243000000.00
TAK income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 124243000000.00
TAK cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: 124279000000.00
TAK income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 124279000000.00
TAK cash_flow (quarterly, 2025-06-30) — Net Intangibles Purchase And Sale: -27155000000.00
TAK income_statement (quarterly, 2025-06-30) — Net Interest Income: -33400000000.00
TAK cash_flow (quarterly, 2025-06-30) — Net Investment Purchase And Sale: 913000000.00
TAK cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: 22000000.00
TAK cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: 46054000000.00
TAK income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -33400000000.00
TAK cash_flow (quarterly, 2025-06-30) — Net Other Financing Charges: -1332000000.00
TAK cash_flow (quarterly, 2025-06-30) — Net Other Investing Changes: 186000000.00
TAK balance_sheet (quarterly, 2025-06-30) — Net PPE: 1956269000000.00
TAK cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -41528000000.00
TAK cash_flow (quarterly, 2025-06-30) — Net Short Term Debt Issuance: -46032000000.00
TAK balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: -1853154000000.00
TAK balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Assets: 401058000000.00
TAK balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Liabilities: 33514000000.00
TAK balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Assets: 401058000000.00
TAK balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Liabilities: 33514000000.00
TAK balance_sheet (quarterly, 2025-06-30) — Non Current Pension And Other Postretirement Benefit Plans: 141512000000.00
TAK income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 439424000000.00
TAK income_statement (quarterly, 2025-06-30) — Normalized Income: 124243000000.00
TAK cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 215423000000.00
TAK cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: -16780000000.00
TAK income_statement (quarterly, 2025-06-30) — Operating Income: 184565000000.00
TAK income_statement (quarterly, 2025-06-30) — Operating Revenue: 1106685000000.00
TAK balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 1561993853.00
TAK balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 173740000000.00
TAK balance_sheet (quarterly, 2025-06-30) — Other Current Borrowings: 371143000000.00
TAK balance_sheet (quarterly, 2025-06-30) — Other Current Liabilities: 722101000000.00
TAK balance_sheet (quarterly, 2025-06-30) — Other Equity Interest: 2347471000000.00
TAK income_statement (quarterly, 2025-06-30) — Other Income Expense: -536000000.00
TAK balance_sheet (quarterly, 2025-06-30) — Other Intangible Assets: 3422542000000.00
TAK cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: -53019000000.00
TAK balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 68555000000.00
TAK balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: 624285000000.00
TAK income_statement (quarterly, 2025-06-30) — Other Operating Expenses: 6031000000.00
TAK balance_sheet (quarterly, 2025-06-30) — Other Short Term Investments: 69167000000.00
TAK balance_sheet (quarterly, 2025-06-30) — Payables: 572273000000.00
TAK balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 572273000000.00
TAK income_statement (quarterly, 2025-06-30) — Pretax Income: 150630000000.00
TAK cash_flow (quarterly, 2025-06-30) — Purchase Of Intangibles: -27155000000.00
TAK cash_flow (quarterly, 2025-06-30) — Purchase Of Investment: -215000000.00
TAK cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -47913000000.00
TAK balance_sheet (quarterly, 2025-06-30) — Receivables: 679531000000.00
TAK income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 334677000000.00
TAK income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 181636000000.00
TAK cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: -183533000000.00
TAK cash_flow (quarterly, 2025-06-30) — Repurchase Of Capital Stock: -51603000000.00
TAK income_statement (quarterly, 2025-06-30) — Research And Development: 143891000000.00
TAK balance_sheet (quarterly, 2025-06-30) — Retained Earnings: 1156692000000.00
TAK cash_flow (quarterly, 2025-06-30) — Sale Of Business: 29291000000.00
TAK cash_flow (quarterly, 2025-06-30) — Sale Of Investment: 1128000000.00
TAK cash_flow (quarterly, 2025-06-30) — Sale Of PPE: 6385000000.00
TAK income_statement (quarterly, 2025-06-30) — Selling General And Administration: 255885000000.00
TAK balance_sheet (quarterly, 2025-06-30) — Share Issued: 1590962609.00
TAK cash_flow (quarterly, 2025-06-30) — Short Term Debt Payments: -46032000000.00
TAK cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 16531000000.00
TAK balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 6865259000000.00
TAK balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: -1853154000000.00
TAK income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
TAK income_statement (quarterly, 2025-06-30) — Tax Provision: 26351000000.00
TAK income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.17
TAK balance_sheet (quarterly, 2025-06-30) — Taxes Receivable: 13899000000.00
TAK cash_flow (quarterly, 2025-06-30) — Taxes Refund Paid: -32995000000.00
TAK balance_sheet (quarterly, 2025-06-30) — Total Assets: 14004537000000.00
TAK balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 11000058000000.00
TAK balance_sheet (quarterly, 2025-06-30) — Total Debt: 4505942000000.00
TAK balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 6866180000000.00
TAK income_statement (quarterly, 2025-06-30) — Total Expenses: 922120000000.00
TAK balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 7138357000000.00
TAK balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 11491415000000.00
TAK balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 4968771000000.00
TAK income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: 184566000000.00
TAK balance_sheet (quarterly, 2025-06-30) — Total Tax Payable: 150965000000.00
TAK balance_sheet (quarterly, 2025-06-30) — Tradeand Other Payables Non Current: 396000000.00
TAK balance_sheet (quarterly, 2025-06-30) — Treasury Shares Number: 28968756.00
TAK balance_sheet (quarterly, 2025-06-30) — Treasury Stock: 124124000000.00
TAK cash_flow (quarterly, 2025-06-30) — Unrealized Gain Loss On Investment Securities: 764000000.00
TAK balance_sheet (quarterly, 2025-06-30) — Working Capital: 343536000000.00
TAK income_statement (quarterly, 2025-09-30) — +Operating Expense: 663739000000.00
TAK income_statement (quarterly, 2025-09-30) — +Total Revenue: 1112796000000.00
TAK balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 438985000000.00
TAK balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 688963000000.00
TAK balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 1734685000000.00
TAK income_statement (quarterly, 2025-09-30) — Amortization: 205155000000.00
TAK income_statement (quarterly, 2025-09-30) — Amortization Of Intangibles Income Statement: 205155000000.00
TAK cash_flow (quarterly, 2025-09-30) — Asset Impairment Charge: 84786000000.00
TAK balance_sheet (quarterly, 2025-09-30) — Assets Held For Sale Current: 12832000000.00
TAK balance_sheet (quarterly, 2025-09-30) — Available For Sale Securities: 365413000000.00
TAK cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 350008000000.00
TAK cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -52825000000.00
TAK balance_sheet (quarterly, 2025-09-30) — Capital Stock: 1694759000000.00
TAK balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 681486000000.00
TAK balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 739678000000.00
TAK cash_flow (quarterly, 2025-09-30) — Cash Dividends Paid: -8787000000.00
TAK cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: -11980000000.00
TAK cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -48134000000.00
TAK cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: 378229000000.00
TAK cash_flow (quarterly, 2025-09-30) — Change In Inventory: -28962000000.00
TAK cash_flow (quarterly, 2025-09-30) — Change In Other Current Liabilities: 12222000000.00
TAK cash_flow (quarterly, 2025-09-30) — Change In Other Working Capital: 31937000000.00
TAK cash_flow (quarterly, 2025-09-30) — Change In Payable: 16538000000.00
TAK cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: 16538000000.00
TAK cash_flow (quarterly, 2025-09-30) — Change In Receivables: -9797000000.00
TAK cash_flow (quarterly, 2025-09-30) — Change In Working Capital: 21938000000.00
TAK cash_flow (quarterly, 2025-09-30) — Changes In Cash: 318114000000.00
TAK balance_sheet (quarterly, 2025-09-30) — Common Stock: 1694759000000.00
TAK balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 7130697000000.00
TAK cash_flow (quarterly, 2025-09-30) — Common Stock Payments: 0.00
TAK income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 380061000000.00
TAK balance_sheet (quarterly, 2025-09-30) — Current Assets: 2920620000000.00
TAK balance_sheet (quarterly, 2025-09-30) — Current Debt: 293858000000.00
TAK balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 293858000000.00
TAK balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 2139655000000.00
TAK balance_sheet (quarterly, 2025-09-30) — Current Provisions: 551523000000.00
TAK cash_flow (quarterly, 2025-09-30) — Deferred Income Tax: 39903000000.00
TAK cash_flow (quarterly, 2025-09-30) — Deferred Tax: 39903000000.00
TAK cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 184982000000.00
TAK income_statement (quarterly, 2025-09-30) — Depreciation Amortization Depletion Income Statement: 205155000000.00
TAK cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 184982000000.00
TAK income_statement (quarterly, 2025-09-30) — Depreciation And Amortization In Income Statement: 205155000000.00
TAK income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: -11802000000.00
TAK cash_flow (quarterly, 2025-09-30) — Dividends Received Cfi: 334000000.00
TAK income_statement (quarterly, 2025-09-30) — EBIT: 111312000000.00
TAK income_statement (quarterly, 2025-09-30) — EBITDA: 316467000000.00
TAK income_statement (quarterly, 2025-09-30) — Earnings From Equity Interest: -2079000000.00
TAK cash_flow (quarterly, 2025-09-30) — Earnings Losses From Equity Investments: 2079000000.00
TAK cash_flow (quarterly, 2025-09-30) — Effect Of Exchange Rate Changes: 13364000000.00
TAK balance_sheet (quarterly, 2025-09-30) — Employee Benefits: 144101000000.00
TAK cash_flow (quarterly, 2025-09-30) — End Cash Position: 681486000000.00
TAK cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: -11981000000.00
TAK cash_flow (quarterly, 2025-09-30) — Free Cash Flow: 325403000000.00
TAK cash_flow (quarterly, 2025-09-30) — Gain Loss On Sale Of Business: -29000000.00
TAK cash_flow (quarterly, 2025-09-30) — Gain Loss On Sale Of PPE: 332000000.00
TAK balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: -3595000000.00
TAK balance_sheet (quarterly, 2025-09-30) — Goodwill: 5431698000000.00
TAK balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 8730923000000.00
TAK income_statement (quarterly, 2025-09-30) — Gross Profit: 732735000000.00
TAK balance_sheet (quarterly, 2025-09-30) — Income Tax Payable: 122907000000.00
TAK income_statement (quarterly, 2025-09-30) — Interest Expense: 83138000000.00
TAK income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 83138000000.00
TAK income_statement (quarterly, 2025-09-30) — Interest Income: 44396000000.00
TAK income_statement (quarterly, 2025-09-30) — Interest Income Non Operating: 44396000000.00
TAK cash_flow (quarterly, 2025-09-30) — Interest Paid Cff: -35604000000.00
TAK cash_flow (quarterly, 2025-09-30) — Interest Received Cfi: 2876000000.00
TAK balance_sheet (quarterly, 2025-09-30) — Inventory: 1299486000000.00
TAK balance_sheet (quarterly, 2025-09-30) — Invested Capital: 11776017000000.00
TAK cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -48133000000.00
TAK balance_sheet (quarterly, 2025-09-30) — Investmentin Financial Assets: 365413000000.00
TAK balance_sheet (quarterly, 2025-09-30) — Investments And Advances: 374332000000.00
TAK cash_flow (quarterly, 2025-09-30) — Issuance Of Debt: 342505000000.00
TAK balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 4351462000000.00
TAK balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 4351462000000.00
TAK cash_flow (quarterly, 2025-09-30) — Long Term Debt Issuance: 342505000000.00
TAK cash_flow (quarterly, 2025-09-30) — Long Term Debt Payments: -10202000000.00
TAK balance_sheet (quarterly, 2025-09-30) — Long Term Equity Investment: 8919000000.00
TAK balance_sheet (quarterly, 2025-09-30) — Long Term Provisions: 32766000000.00
TAK balance_sheet (quarterly, 2025-09-30) — Minority Interest: 992000000.00
TAK income_statement (quarterly, 2025-09-30) — Minority Interests: -72000000.00
TAK cash_flow (quarterly, 2025-09-30) — Net Business Purchase And Sale: 417000000.00
TAK cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: 0.00
TAK balance_sheet (quarterly, 2025-09-30) — Net Debt: 3963834000000.00
TAK income_statement (quarterly, 2025-09-30) — Net Income: -11802000000.00
TAK income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: -11802000000.00
TAK income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: -11729000000.00
TAK income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: -11802000000.00
TAK income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: -11802000000.00
TAK cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: -11729000000.00
TAK income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: -11729000000.00
TAK cash_flow (quarterly, 2025-09-30) — Net Intangibles Purchase And Sale: -12730000000.00
TAK income_statement (quarterly, 2025-09-30) — Net Interest Income: -38742000000.00
TAK cash_flow (quarterly, 2025-09-30) — Net Investment Purchase And Sale: 1332000000.00
TAK cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: 36555000000.00
TAK cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: 332303000000.00
TAK income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -38742000000.00
TAK cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: -4145000000.00
TAK cash_flow (quarterly, 2025-09-30) — Net Other Investing Changes: -267000000.00
TAK balance_sheet (quarterly, 2025-09-30) — Net PPE: 1984126000000.00
TAK cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -40095000000.00
TAK cash_flow (quarterly, 2025-09-30) — Net Short Term Debt Issuance: -295748000000.00
TAK balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: -1600226000000.00
TAK balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Assets: 389768000000.00
TAK balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Liabilities: 33029000000.00
TAK balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Assets: 389768000000.00
TAK balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Liabilities: 33029000000.00
TAK balance_sheet (quarterly, 2025-09-30) — Non Current Pension And Other Postretirement Benefit Plans: 144101000000.00
TAK income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 316467000000.00
TAK income_statement (quarterly, 2025-09-30) — Normalized Income: -11802000000.00
TAK cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: 378228000000.00
TAK cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: 2382000000.00
TAK income_statement (quarterly, 2025-09-30) — Operating Income: 68996000000.00
TAK income_statement (quarterly, 2025-09-30) — Operating Revenue: 1112796000000.00
TAK balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 1579594274.00
TAK balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 166386000000.00
TAK balance_sheet (quarterly, 2025-09-30) — Other Current Borrowings: 293858000000.00
TAK balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 732382000000.00
TAK balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: -3595000000.00
TAK balance_sheet (quarterly, 2025-09-30) — Other Equity Interest: 2605314000000.00
TAK income_statement (quarterly, 2025-09-30) — Other Income Expense: -2079000000.00
TAK balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 3299225000000.00
TAK cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 90371000000.00
TAK balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 70531000000.00
TAK balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 635291000000.00
TAK income_statement (quarterly, 2025-09-30) — Other Operating Expenses: 43551000000.00
TAK balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 58192000000.00
TAK balance_sheet (quarterly, 2025-09-30) — Payables: 561892000000.00
TAK balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 561892000000.00
TAK income_statement (quarterly, 2025-09-30) — Pretax Income: 28174000000.00
TAK cash_flow (quarterly, 2025-09-30) — Purchase Of Intangibles: -12730000000.00
TAK cash_flow (quarterly, 2025-09-30) — Purchase Of Investment: -1550000000.00
TAK cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -40095000000.00
TAK balance_sheet (quarterly, 2025-09-30) — Receivables: 702238000000.00
TAK income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 400234000000.00
TAK income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 184982000000.00
TAK cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: 35830000000.00
TAK cash_flow (quarterly, 2025-09-30) — Repurchase Of Capital Stock: 0.00
TAK income_statement (quarterly, 2025-09-30) — Research And Development: 161482000000.00
TAK balance_sheet (quarterly, 2025-09-30) — Retained Earnings: 1148658000000.00
TAK cash_flow (quarterly, 2025-09-30) — Sale Of Business: 1040000000.00
TAK cash_flow (quarterly, 2025-09-30) — Sale Of Investment: 2882000000.00
TAK cash_flow (quarterly, 2025-09-30) — Sale Of PPE: 0.00
TAK income_statement (quarterly, 2025-09-30) — Selling General And Administration: 253551000000.00
TAK balance_sheet (quarterly, 2025-09-30) — Share Issued: 1590985809.00
TAK cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 18731000000.00
TAK balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 7130697000000.00
TAK balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: -1600226000000.00
TAK income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
TAK income_statement (quarterly, 2025-09-30) — Tax Provision: 39903000000.00
TAK income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.23
TAK balance_sheet (quarterly, 2025-09-30) — Taxes Receivable: 13275000000.00
TAK cash_flow (quarterly, 2025-09-30) — Taxes Refund Paid: -53361000000.00
TAK balance_sheet (quarterly, 2025-09-30) — Total Assets: 14470300000000.00
TAK balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 11482159000000.00
TAK balance_sheet (quarterly, 2025-09-30) — Total Debt: 4645320000000.00
TAK balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 7131689000000.00
TAK income_statement (quarterly, 2025-09-30) — Total Expenses: 1043800000000.00
TAK balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 7338611000000.00
TAK balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 11549680000000.00
TAK balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 5198956000000.00
TAK income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: 68995000000.00
TAK balance_sheet (quarterly, 2025-09-30) — Total Tax Payable: 122907000000.00
TAK balance_sheet (quarterly, 2025-09-30) — Tradeand Other Payables Non Current: 2307000000.00
TAK balance_sheet (quarterly, 2025-09-30) — Treasury Shares Number: 11391535.00
TAK balance_sheet (quarterly, 2025-09-30) — Treasury Stock: 49124000000.00
TAK cash_flow (quarterly, 2025-09-30) — Unrealized Gain Loss On Investment Securities: 225000000.00
TAK balance_sheet (quarterly, 2025-09-30) — Working Capital: 780965000000.00
TAK income_statement (quarterly, 2025-12-31) — +Operating Expense: 621728000000.00
TAK income_statement (quarterly, 2025-12-31) — +Total Revenue: 1191698000000.00
TAK balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 467594000000.00
TAK balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 736464000000.00
TAK balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 1751906000000.00
TAK income_statement (quarterly, 2025-12-31) — Amortization: 141914000000.00
TAK income_statement (quarterly, 2025-12-31) — Amortization Of Intangibles Income Statement: 141914000000.00
TAK cash_flow (quarterly, 2025-12-31) — Asset Impairment Charge: 7647000000.00
TAK balance_sheet (quarterly, 2025-12-31) — Assets Held For Sale Current: 13602000000.00
TAK balance_sheet (quarterly, 2025-12-31) — Available For Sale Securities: 423979000000.00
TAK cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 681486000000.00
TAK cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -222373000000.00
TAK balance_sheet (quarterly, 2025-12-31) — Capital Stock: 1694763000000.00
TAK balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 654937000000.00
TAK balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 761941000000.00
TAK cash_flow (quarterly, 2025-12-31) — Cash Dividends Paid: -149032000000.00
TAK cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: -192447000000.00
TAK cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -229797000000.00
TAK cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 373251000000.00
TAK cash_flow (quarterly, 2025-12-31) — Change In Inventory: -37962000000.00
TAK cash_flow (quarterly, 2025-12-31) — Change In Other Current Liabilities: 20068000000.00
TAK cash_flow (quarterly, 2025-12-31) — Change In Other Working Capital: -13794000000.00
TAK cash_flow (quarterly, 2025-12-31) — Change In Payable: 3293000000.00
TAK cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: 3293000000.00
TAK cash_flow (quarterly, 2025-12-31) — Change In Receivables: -10936000000.00
TAK cash_flow (quarterly, 2025-12-31) — Change In Working Capital: -39331000000.00
TAK cash_flow (quarterly, 2025-12-31) — Changes In Cash: -48993000000.00
TAK balance_sheet (quarterly, 2025-12-31) — Common Stock: 1694763000000.00
TAK balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 7642943000000.00
TAK cash_flow (quarterly, 2025-12-31) — Common Stock Payments: 0.00
TAK income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 401148000000.00
TAK balance_sheet (quarterly, 2025-12-31) — Current Assets: 3116439000000.00
TAK balance_sheet (quarterly, 2025-12-31) — Current Debt: 583147000000.00
TAK balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 583147000000.00
TAK balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 2610183000000.00
TAK balance_sheet (quarterly, 2025-12-31) — Current Provisions: 572131000000.00
TAK cash_flow (quarterly, 2025-12-31) — Deferred Income Tax: 30131000000.00
TAK cash_flow (quarterly, 2025-12-31) — Deferred Tax: 30131000000.00
TAK cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 190639000000.00
TAK income_statement (quarterly, 2025-12-31) — Depreciation Amortization Depletion Income Statement: 141914000000.00
TAK cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 190639000000.00
TAK income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 141914000000.00
TAK income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 103640000000.00
TAK cash_flow (quarterly, 2025-12-31) — Dividends Received Cfi: 72000000.00
TAK income_statement (quarterly, 2025-12-31) — EBIT: 257491000000.00
TAK income_statement (quarterly, 2025-12-31) — EBITDA: 448130000000.00
TAK income_statement (quarterly, 2025-12-31) — Earnings From Equity Interest: 799000000.00
TAK cash_flow (quarterly, 2025-12-31) — Earnings Losses From Equity Investments: -799000000.00
TAK cash_flow (quarterly, 2025-12-31) — Effect Of Exchange Rate Changes: 22444000000.00
TAK balance_sheet (quarterly, 2025-12-31) — Employee Benefits: 150595000000.00
TAK cash_flow (quarterly, 2025-12-31) — End Cash Position: 654937000000.00
TAK cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: -192447000000.00
TAK cash_flow (quarterly, 2025-12-31) — Free Cash Flow: 150879000000.00
TAK cash_flow (quarterly, 2025-12-31) — Gain Loss On Sale Of Business: 0.00
TAK cash_flow (quarterly, 2025-12-31) — Gain Loss On Sale Of PPE: 358000000.00
TAK balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -2943000000.00
TAK balance_sheet (quarterly, 2025-12-31) — Goodwill: 5753268000000.00
TAK balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 9268896000000.00
TAK income_statement (quarterly, 2025-12-31) — Gross Profit: 790550000000.00
TAK balance_sheet (quarterly, 2025-12-31) — Income Tax Payable: 148336000000.00
TAK income_statement (quarterly, 2025-12-31) — Interest Expense: 123627000000.00
TAK income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 123627000000.00
TAK income_statement (quarterly, 2025-12-31) — Interest Income: 87871000000.00
TAK income_statement (quarterly, 2025-12-31) — Interest Income Non Operating: 87871000000.00
TAK cash_flow (quarterly, 2025-12-31) — Interest Paid Cff: -29786000000.00
TAK cash_flow (quarterly, 2025-12-31) — Interest Received Cfi: 5140000000.00
TAK balance_sheet (quarterly, 2025-12-31) — Inventory: 1407192000000.00
TAK balance_sheet (quarterly, 2025-12-31) — Invested Capital: 12496264000000.00
TAK cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -229798000000.00
TAK balance_sheet (quarterly, 2025-12-31) — Investmentin Financial Assets: 423979000000.00
TAK balance_sheet (quarterly, 2025-12-31) — Investments And Advances: 434168000000.00
TAK cash_flow (quarterly, 2025-12-31) — Issuance Of Debt: 0.00
TAK balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 4270174000000.00
TAK balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 4270174000000.00
TAK cash_flow (quarterly, 2025-12-31) — Long Term Debt Issuance: 0.00
TAK cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: -9886000000.00
TAK balance_sheet (quarterly, 2025-12-31) — Long Term Equity Investment: 10189000000.00
TAK balance_sheet (quarterly, 2025-12-31) — Long Term Provisions: 34061000000.00
TAK balance_sheet (quarterly, 2025-12-31) — Minority Interest: 1147000000.00
TAK income_statement (quarterly, 2025-12-31) — Minority Interests: -94000000.00
TAK cash_flow (quarterly, 2025-12-31) — Net Business Purchase And Sale: 3359000000.00
TAK cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: 0.00
TAK balance_sheet (quarterly, 2025-12-31) — Net Debt: 4198384000000.00
TAK income_statement (quarterly, 2025-12-31) — Net Income: 103640000000.00
TAK income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 103640000000.00
TAK income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 103733000000.00
TAK income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 103640000000.00
TAK income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 103640000000.00
TAK cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: 103733000000.00
TAK income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 103733000000.00
TAK cash_flow (quarterly, 2025-12-31) — Net Intangibles Purchase And Sale: -180740000000.00
TAK income_statement (quarterly, 2025-12-31) — Net Interest Income: -35756000000.00
TAK cash_flow (quarterly, 2025-12-31) — Net Investment Purchase And Sale: -13368000000.00
TAK cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: -9886000000.00
TAK cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: -9886000000.00
TAK income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -35756000000.00
TAK cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: -3743000000.00
TAK cash_flow (quarterly, 2025-12-31) — Net Other Investing Changes: -2643000000.00
TAK balance_sheet (quarterly, 2025-12-31) — Net PPE: 2083981000000.00
TAK cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -41618000000.00
TAK cash_flow (quarterly, 2025-12-31) — Net Short Term Debt Issuance: 0.00
TAK balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: -1625953000000.00
TAK balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Assets: 427490000000.00
TAK balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Liabilities: 31282000000.00
TAK balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Assets: 427490000000.00
TAK balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Liabilities: 31282000000.00
TAK balance_sheet (quarterly, 2025-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 150595000000.00
TAK income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 448130000000.00
TAK income_statement (quarterly, 2025-12-31) — Normalized Income: 103640000000.00
TAK cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 373252000000.00
TAK cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: -441000000.00
TAK income_statement (quarterly, 2025-12-31) — Operating Income: 168822000000.00
TAK income_statement (quarterly, 2025-12-31) — Operating Revenue: 1191698000000.00
TAK balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 1579596411.00
TAK balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 175783000000.00
TAK balance_sheet (quarterly, 2025-12-31) — Other Current Borrowings: 583147000000.00
TAK balance_sheet (quarterly, 2025-12-31) — Other Current Liabilities: 838975000000.00
TAK balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: -2943000000.00
TAK balance_sheet (quarterly, 2025-12-31) — Other Equity Interest: 3152679000000.00
TAK income_statement (quarterly, 2025-12-31) — Other Income Expense: 799000000.00
TAK balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 3515628000000.00
TAK cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: 85091000000.00
TAK balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 77798000000.00
TAK balance_sheet (quarterly, 2025-12-31) — Other Non Current Liabilities: 665118000000.00
TAK income_statement (quarterly, 2025-12-31) — Other Operating Expenses: 21800000000.00
TAK balance_sheet (quarterly, 2025-12-31) — Other Short Term Investments: 107004000000.00
TAK balance_sheet (quarterly, 2025-12-31) — Payables: 615930000000.00
TAK balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 615930000000.00
TAK income_statement (quarterly, 2025-12-31) — Pretax Income: 133864000000.00
TAK cash_flow (quarterly, 2025-12-31) — Purchase Of Business: 0.00
TAK cash_flow (quarterly, 2025-12-31) — Purchase Of Intangibles: -180740000000.00
TAK cash_flow (quarterly, 2025-12-31) — Purchase Of Investment: -14928000000.00
TAK cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -41633000000.00
TAK balance_sheet (quarterly, 2025-12-31) — Receivables: 757921000000.00
TAK income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 352423000000.00
TAK income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 190639000000.00
TAK cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: -9886000000.00
TAK cash_flow (quarterly, 2025-12-31) — Repurchase Of Capital Stock: 0.00
TAK income_statement (quarterly, 2025-12-31) — Research And Development: 175231000000.00
TAK balance_sheet (quarterly, 2025-12-31) — Retained Earnings: 1095662000000.00
TAK cash_flow (quarterly, 2025-12-31) — Sale Of Business: 3359000000.00
TAK cash_flow (quarterly, 2025-12-31) — Sale Of Investment: 1560000000.00
TAK cash_flow (quarterly, 2025-12-31) — Sale Of PPE: 15000000.00
TAK income_statement (quarterly, 2025-12-31) — Selling General And Administration: 282783000000.00
TAK balance_sheet (quarterly, 2025-12-31) — Share Issued: 1590987809.00
TAK cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 17802000000.00
TAK balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 7642943000000.00
TAK balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: -1625953000000.00
TAK income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
TAK income_statement (quarterly, 2025-12-31) — Tax Provision: 30131000000.00
TAK income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.23
TAK balance_sheet (quarterly, 2025-12-31) — Taxes Receivable: 21457000000.00
TAK cash_flow (quarterly, 2025-12-31) — Taxes Refund Paid: -22087000000.00
TAK balance_sheet (quarterly, 2025-12-31) — Total Assets: 15408774000000.00
TAK balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 11913117000000.00
TAK balance_sheet (quarterly, 2025-12-31) — Total Debt: 4853321000000.00
TAK balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 7644090000000.00
TAK income_statement (quarterly, 2025-12-31) — Total Expenses: 1022876000000.00
TAK balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 7764684000000.00
TAK balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 12292333000000.00
TAK balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 5154501000000.00
TAK income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: 168821000000.00
TAK balance_sheet (quarterly, 2025-12-31) — Total Tax Payable: 148336000000.00
TAK balance_sheet (quarterly, 2025-12-31) — Tradeand Other Payables Non Current: 3271000000.00
TAK balance_sheet (quarterly, 2025-12-31) — Treasury Shares Number: 11391398.00
TAK balance_sheet (quarterly, 2025-12-31) — Treasury Stock: 49124000000.00
TAK cash_flow (quarterly, 2025-12-31) — Unrealized Gain Loss On Investment Securities: 68000000.00
TAK balance_sheet (quarterly, 2025-12-31) — Working Capital: 506256000000.00
TAK income_statement (annual, 2026-03-31) — +Operating Expense: 2469681000000.00
TAK income_statement (quarterly, 2026-03-31) — +Operating Expense: 646769000000.00
TAK income_statement (annual, 2026-03-31) — +Total Revenue: 4505720000000.00
TAK income_statement (quarterly, 2026-03-31) — +Total Revenue: 1094541000000.00
TAK balance_sheet (annual, 2026-03-31) — Accounts Payable: 324368000000.00
TAK balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 324368000000.00
TAK balance_sheet (annual, 2026-03-31) — Accounts Receivable: 977355000000.00
TAK balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 977355000000.00
TAK balance_sheet (annual, 2026-03-31) — Accumulated Depreciation: -1531870000000.00
TAK balance_sheet (quarterly, 2026-03-31) — Accumulated Depreciation: -1531870000000.00
TAK balance_sheet (annual, 2026-03-31) — Additional Paid In Capital: 1776352000000.00
TAK balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 1776352000000.00
TAK income_statement (annual, 2026-03-31) — Amortization: 633544000000.00
TAK income_statement (quarterly, 2026-03-31) — Amortization: 154837000000.00
TAK income_statement (annual, 2026-03-31) — Amortization Of Intangibles Income Statement: 633544000000.00
TAK income_statement (quarterly, 2026-03-31) — Amortization Of Intangibles Income Statement: 154837000000.00
TAK cash_flow (annual, 2026-03-31) — Asset Impairment Charge: 145716000000.00
TAK cash_flow (quarterly, 2026-03-31) — Asset Impairment Charge: 50926000000.00
TAK balance_sheet (annual, 2026-03-31) — Assets Held For Sale Current: 17955000000.00
TAK balance_sheet (quarterly, 2026-03-31) — Assets Held For Sale Current: 17955000000.00
TAK balance_sheet (annual, 2026-03-31) — Available For Sale Securities: 439941000000.00
TAK balance_sheet (quarterly, 2026-03-31) — Available For Sale Securities: 439941000000.00
TAK cash_flow (annual, 2026-03-31) — Beginning Cash Position: 385113000000.00
TAK cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 654937000000.00
TAK balance_sheet (annual, 2026-03-31) — Buildings And Improvements: 1836073000000.00
TAK balance_sheet (quarterly, 2026-03-31) — Buildings And Improvements: 1836073000000.00
TAK cash_flow (annual, 2026-03-31) — Capital Expenditure: -414659000000.00
TAK cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -64393000000.00
TAK balance_sheet (annual, 2026-03-31) — Capital Stock: 1695277000000.00
TAK balance_sheet (quarterly, 2026-03-31) — Capital Stock: 1695277000000.00
TAK balance_sheet (annual, 2026-03-31) — Cash And Cash Equivalents: 595054000000.00
TAK balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 595054000000.00
TAK balance_sheet (annual, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 636942000000.00
TAK balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 636942000000.00
TAK cash_flow (annual, 2026-03-31) — Cash Dividends Paid: -311901000000.00
TAK cash_flow (quarterly, 2026-03-31) — Cash Dividends Paid: -8787000000.00
TAK balance_sheet (annual, 2026-03-31) — Cash Equivalents: 450294000000.00
TAK balance_sheet (quarterly, 2026-03-31) — Cash Equivalents: 450294000000.00
TAK balance_sheet (annual, 2026-03-31) — Cash Financial: 144760000000.00
TAK balance_sheet (quarterly, 2026-03-31) — Cash Financial: 144760000000.00
TAK cash_flow (annual, 2026-03-31) — Cash Flow From Continuing Financing Activities: -496819000000.00
TAK cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: -77492000000.00
TAK cash_flow (annual, 2026-03-31) — Cash Flow From Continuing Investing Activities: -369141000000.00
TAK cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -58017000000.00
TAK cash_flow (annual, 2026-03-31) — Cash Flow From Continuing Operating Activities: 1041432000000.00
TAK cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: 74530000000.00
TAK cash_flow (annual, 2026-03-31) — Change In Inventory: -61293000000.00
TAK cash_flow (quarterly, 2026-03-31) — Change In Inventory: 18700000000.00
TAK cash_flow (annual, 2026-03-31) — Change In Other Current Liabilities: -81606000000.00
TAK cash_flow (quarterly, 2026-03-31) — Change In Other Current Liabilities: -96365000000.00
TAK cash_flow (annual, 2026-03-31) — Change In Other Working Capital: 416120000000.00
TAK cash_flow (quarterly, 2026-03-31) — Change In Other Working Capital: 421381000000.00
TAK cash_flow (annual, 2026-03-31) — Change In Payable: -3150000000.00
TAK cash_flow (quarterly, 2026-03-31) — Change In Payable: 4799000000.00
TAK cash_flow (annual, 2026-03-31) — Change In Payables And Accrued Expense: -3150000000.00
TAK cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: 4799000000.00